Aarti Drugs Ltd (NSE: AARTIDRUGS) has been trading within a well-defined parallel channel on the monthly timeframe since 2009. The stock is currently at the bottom of the channel, having successfully retested the channel support. This retest could signify a potential bounce, presenting a long-term buying opportunity.
The RSI is also on an upward trajectory.
Sharing this analysis for Long-Term investors.
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Always conduct your own research before making any investment decisions.